Take a good look at these Houston entrepreneurs' faces, because you might be seeing them in downtown Austin next weekend for SXSW. Photos courtesy

Welcome to a special edition of InnovationMap's weekly innovators to know series. This week has more innovators featured than ever, and we're highlighting a particular group of people: The Houston founders headed for SXSW in Austin later this week. From startup founders, coworking space leaders, and pitch competition organizers, here's the Houston SXSW attendees you should know about.

Scott Parazynski, CEO of Fluidity Technologies

Courtesy of Fluidity

Houston-based Fluidity Technologies and its drone controller, FT Aviator, will be presenting at the 11th annual SXSW Pitch event on Saturday, March 9, at 5 p.m. The company has been named a finalist in the Hyper-Connected Communities category. Fluidity is lead by CEO Scott Parazynski, a former NASA astronaut, pilot, and physician. The FT Aviator has the potential to revolutionize drone technology. The joystick-like controller is based off movement in space, Parazynski says, and is less prone to user error by someone not as well trained in drone operation.

Fluidity will find out if it wins in its category on Sunday, March 10, at 6:30 p.m. at the SXSW Pitch awards program.

Lawson Gow, founder and CEO of The Cannon

Courtesy of The Cannon

There's no better setting to talk Texas entrepreneurialism than a stage at SXSW, and that's what Lawson Gow, founder and CEO of The Cannon, is going to be doing on the "Austinpreneur: The Texas Startup Manifesto" panel presented by Capital Factory on Saturday, March 9, at 11 am.

Gow, who is the son of InnovationMap's parent company's CEO, has been juggling a lot since the launch of Cannon Ventures last year and the anticipation of The Cannon's new West Houston 120,000-square-foot facility, which is expected to deliver in May.

Gabriella Rowe, CEO of Station Houston

Courtesy of Station Houston

Gabriella Rowe, the fearless leader of startup acceleration hub, Station Houston, is headed for the state capital to talk, well, capital. Rowe will be a panelist on the "Startup Funding: From Apprenticeships to Professions" panel on Saturday, March 9, at 12:30 pm.

Rowe has served as CEO of Station Houston since August. The nonprofit has a lot going on ahead of The Ion's launch, of which the Station is the programming partner. Read more about that — and why Rowe says wild horses couldn't drag her out of Houston —in her Featured Innovator piece.

Katharine Forth, founder and CEO of Zibrio

Courtesy of Zibrio

Another Houston company selected as a finalist of the 11th annual SXSW Pitch event is Zibrio SmartScale, which is in the Health and Wearable category and is presenting on Sunday, March 10, at 5 pm. The company is all about balance. Its product, a smart scale that tracks balance, aims to reduce dangers that come with poor balance — injuries, deaths, and costs from falls. Katharine Forth leads the company as CEO and founder. The company was a member of TMCx's 2015 medical devices cohort.

Right after pitching, Forth will find out if her company wins in its category on Sunday, March 10, at 6:30 p.m. at the SXSW Pitch awards program.

Greg Wright, founder of HATCH Pitch

Courtesy of HATCH

For the eighth year, Houston-based HATCH Pitch is headed to Austin for SXSW to host its pitch competition focused on startups making the world a better place. Greg Wright, founder of the pitch program, will be there leading the event, which takes place on Monday, March 11, from 10 am to noon. The competition will be between four finalists. While only invited guests guests can attend, the pitches will be streamed online in an interactive way, so viewers can post comments or questions to the mentors, pitchers, and judges.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas lands top 10 spot in new future of tech study

report

Texas is among the top 10 states making the biggest investments in digital innovation, according to a new study.

The study, conducted by web-hosting company Hostinger, puts Texas in eighth place among the states when it comes to these key metrics:

  • Financial impact of the digital economy
  • Amount of venture capital and grants received by digital startups
  • Number of government-run tech hubs
  • Presence of top-rated business incubators

“To many, the Texas story is one of oil magnates and real estate tycoons. But in recent decades, the state has emerged as an innovation and high-tech hub,” according to a report from the Federal Reserve Bank of Dallas.

On a scale of 1 to 100, Texas received a score of 79. California nabbed the top spot with a score of 100. Appearing behind California and ahead of Texas in the ranking are:

  • No. 2: New York
  • No. 3: Washington
  • No. 4: Illinois
  • No. 5: Massachusetts
  • No. 6: Missouri
  • No. 7: Wisconsin

In terms of ranking factors, Texas benefited the most from landing at No. 2 among the states for its impact on the digital economy. The study pegged Texas’ digital economic impact at $141.7 billion, well below California’s impact of $492.8 billion.

Hostinger relied primarily on government data on 31 states to come up with the ranking. “The research provides a detailed ranking based on a composite score that reflects each state's overall investment and capacity for digital innovation,” the company says.

More than 30,000 businesses in Texas participate in the digital economy, according to the Computer & Communications Industry Association (CCIA). Those businesses employ more than 633,000 people and account for over six percent of the state’s GDP, a key measure of economic strength.

“As technology companies face increasing scrutiny through state and national legislation and litigation, it’s crucial to recognize the significant positive impacts of the digital economy that resonate across the United States,” says the CCIA.

TMC names 2025 cohort of cancer treatment innovators

ready to grow

Texas Medical Center Innovation has named more than 50 health care innovators to the fifth cohort of its Accelerator for Cancer Therapeutics (ACT).

The group specializes in immunotherapy, precision drug discovery, monoclonal antibodies, and diagnostic and therapeutic technologies, according to a statement from TMC.

During the nine-month ACT program, participants will enjoy access to a network of mentors, grant-writing support, chemistry resources, and the entrepreneur-in-residence program. The program is designed to equip participants with the ability to secure investments, develop partnerships, and advance the commercialization of cancer therapeutics in Texas.

“With over 35 million new cancer cases predicted by 2050, the urgency to develop safer, more effective, and personalized treatments cannot be overstated,” Tom Luby, chief innovation officer at Texas Medical Center, said in a news release.

Members of the new cohort are:

  • Alexandre Reuben, Kunal Rai, Dr. Cassian Yee, Dr. Wantong Yao, Dr. Haoqiang Ying, Xiling Shen, and Zhao Chen, all of the University of Texas MD Anderson Cancer Center
  • Dr. Andre Catic and Dr. Martin M. Matzuk, both of the Baylor College of Medicine
  • Cynthia Hu and Zhiqiang An, both of UTHealth Houston
  • Christopher Powala, Aaron Sato, and Mark de Souza, all of ARespo Biopharma
  • Daniel Romo, Dr. Susan Bates, and Ken Hull, all of Baylor University
  • Eugene Sa & Minseok Kim, both of CTCELLS
  • Gomika Udugamasooriya and Nathaniel Dawkins, both of the University of Houston
  • Dr. Hector Alila of Remunity Therapeutics
  • Iosif Gershteyn and Victor Goldmacher, both of ImmuVia
  • João Seixas, Pedro Cal, and Gonçalo Bernardes, all of TargTex
  • Ken Hsu and Yelena Wetherill, both of the University of Texas at Austin
  • Luis Martin and Dr. Alberto Ocaña, both of C-Therapeutics
  • Dr. Lynda Chin, Dr. Keith Flaherty, Dr. Padmanee Sharma, James Allison, and Ronan O’Hagan, all of Project Crest/Apricity Health
  • Michael Coleman and Shaker Reddy, both of Metaclipse Therapeutics
  • Robert Skiff and Norman Packard, both of 3582.ai
  • Rolf Brekken, Uttam Tambar, Ping Mu, Su Deng, Melanie Rodriguez, and Alexander Busse, all of UT Southwestern Medical Center
  • Ryan Swoboda and Maria Teresa Sabrina Bertilaccio, both of NAVAN Technologies
  • Shu-Hsia Chen and Ping-Ying Pan, both of Houston Methodist
  • Thomas Kim, Philipp Mews, and Eyal Gottlieb, all of ReEngage Therapeutics
The ACT launched in 2021 and has had 77 researchers and companies participate. The group has collectively secured more than $202 million in funding from the NIH, CPRIT and venture capital, according to TMC.